Infectious diseases, along with cancers, are among the main causes of death among
humans worldwide. The production of therapeutic proteins for treating diseases at large …

Recombinant proteins (RP) are widely used as biopharmaceuticals, industrial enzymes, or
sustainable food source. Yeasts, with their ability to produce complex proteins through a …

Reverse vaccinology (RV) was described at its inception in 2000 as an in silico process that
starts from the genomic sequence of the pathogen and ends with a list of potential protein …

The fast-developing synthetic biology (SB) has provided many genetic tools to reprogram
and engineer cells for improved performance, novel functions, and diverse applications …

The depletion of energy resources and environmental concerns have sped up the
development of sustainable energy by combining renewable resources. The biofuel sector …

The management and recycling of plastic waste is a challenging global issue. Polyethylene
terephthalate (PET), one of the most widely used synthetic plastics, can be hydrolyzed by a …

Nowadays, viruses are not only seen as causative agents of viral infectious diseases but
also as valuable research materials for various biomedical purposes, including recombinant …

In view of the growing concern about the impact of synthetic fungicides on human health and
the environment, several government bodies have decided to ban them. As a result, a great …

Rapidly growing yeasts with appropriate posttranslational modifications are favored hosts for
protein production in the biopharmaceutical industry. However, limited production capacity …

Collagen, classically derived from animal tissue, is an all-important protein material widely
used in biomedical materials, cosmetics, fodder, food, etc. The production of recombinant …